Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Pilot Study of FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-type, Left-sided Colorectal Cancer

NCT04169347 is registered in ClinicalTrials.gov with Criterium, Inc. as lead sponsor.

NCT NCT04169347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04169347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Pilot Study of FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-type, Left-sided Colorectal Cancer
Lead sponsor
Criterium, Inc.
Phase
Phase 2
Overall status
Unknown status
Start date
December 2, 2019
Completion date
January 31, 2025
Enrollment
27 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer metastatic